Lymphedema Treatment Act

Actions

• 2017-02-21Referred to the Subcommittee on Health.
• 2017-02-10Referred to the Subcommittee on Health.
• 2017-02-07Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
• 2017-02-07Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
• 2017-02-07Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
• 2017-02-07Introduced in House
• 2017-02-07Introduced in House

CRS Summary

As of 2017-02-07 (00)

Cosponsors (20)

• EARL BLUMENAUER (D-OR)
• Leonard Lance (R-NJ)
• JANICE SCHAKOWSKY (D-IL)
• Brendan Boyle (D-PA)
• Susan Brooks (R-IN)
• Julia Brownley (D-CA)
• PETER DEFAZIO (D-OR)
• ROSA DELAURO (D-CT)
• Suzan DelBene (D-WA)
• Bill Foster (D-IL)
• RODNEY FRELINGHUYSEN (R-NJ)
• Gregg Harper (R-MS)
• Denny Heck (D-WA)
• RON KIND (D-WI)
• Daniel Lipinski (D-IL)
• Michelle Lujan Grisham (D-NM)
• Patrick Meehan (R-PA)
• Markwayne Mullin (R-OK)
• Chellie Pingree (D-ME)
• David Roe (R-TN)

Subjects

• Health technology, devices, supplies
• Immunology and vaccination
• Medicare